Literature DB >> 3444803

Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy.

R Teoh1, J Woo.   

Abstract

The treatment of a patient with euthyroid Graves' ophthalmopathy is described. A poor response was obtained from large doses of prednisone whereas a combination of orbital irradiation and low dose cyclophosphamide induced a dramatic resolution. As there is no fully satisfactory treatment for this condition, this combined therapy deserves further investigation.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3444803      PMCID： PMC2428524          DOI： 10.1136/pgmj.63.743.777

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  8 in total

1.  Ultrasonographic evidence of a consistent orbital involvement in Graves's disease.

Authors:  S C Werner; D J Coleman; L A Franzen
Journal:  N Engl J Med       Date:  1974-06-27       Impact factor: 91.245

2.  Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment.

Authors:  T A Howlett; N F Lawton; P Fells; G M Besser
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

Review 3.  Ocular manifestations of Graves' disease: a review.

Authors:  A P Weetman; A M McGregor; R Hall
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

4.  Cyclosporin improves Graves' ophthalmopathy.

Authors:  A P Weetman; A M McGregor; M Ludgate; L Beck; P V Mills; J H Lazarus; R Hall
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

5.  Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy.

Authors:  K Kodama; H Sikorska; P Bandy-Dafoe; R Bayly; J R Wall
Journal:  Lancet       Date:  1982-12-18       Impact factor: 79.321

6.  Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.

Authors:  L Bartalena; C Marcocci; L Chiovato; M Laddaga; G Lepri; D Andreani; G Cavallacci; L Baschieri; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

7.  Combined short-term immunotherapy for experimental autoimmune myasthenia gravis.

Authors:  A Pestronk; D B Drachman; R Teoh; R N Adams
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

8.  Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy.

Authors:  M Faryna; J Nauman; A Gardas
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19
  8 in total
  1 in total

1.  The pathogenesis and treatment of Graves' ophthalmopathy.

Authors:  I R Jones
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.